| FSSNX | MASMX | FSSNX / MASMX | |
| Total Expense Ratio | 0.03 | 1.35 | 2% |
| Annual Report Gross Expense Ratio | 0.03 | 1.35 | 2% |
| Fund Existence | 14 years | 6 years | - |
| Gain YTD | 6.434 | 4.721 | 136% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 0 | 1000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 29.7B | 156M | 19,038% |
| Annual Yield % from dividends | 1.03 | 0.00 | - |
| Returns for 1 year | 18.62 | -13.55 | -137% |
| Returns for 3 years | 39.32 | -0.91 | -4,303% |
| Returns for 5 years | 25.49 | -27.27 | -93% |
| Returns for 10 years | 169.89 | 21.50 | 790% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| EITEX | 52.65 | 0.62 | +1.19% |
| Parametric Tax-Managed Emerg Mkt I | |||
| QSMRX | 22.41 | 0.21 | +0.95% |
| AQR Small Cap Momentum Style R6 | |||
| ETNHX | 51.17 | 0.44 | +0.87% |
| Eventide Healthcare & Life Sciences N | |||
| RCEAX | 13.06 | 0.05 | +0.38% |
| RBC China Equity A | |||
| FDTTX | 26.87 | N/A | N/A |
| Fidelity Advisor Capital Development A | |||